Document Detail

Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial.
MedLine Citation:
PMID:  18771879     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The optimal first-line treatment for intermittent claudication is currently unclear.
OBJECTIVE: To compare the cost-effectiveness of endovascular revascularization vs supervised hospital-based exercise in patients with intermittent claudication during a 12-month follow-up period.
DESIGN: Randomized controlled trial with patient recruitment between September 2002-September 2006 and a 12-month follow-up per patient.
SETTING: A large community hospital.
PARTICIPANTS: Patients with symptoms of intermittent claudication due to an iliac or femoro-popliteal arterial lesion (293) who fulfilled the inclusion criteria (151) were recruited. Excluded were, for example, patients with lesions unsuitable for revascularization (iliac or femoropopliteal TASC-type D and some TASC type-B/C.
INTERVENTION: Participants were randomly assigned to endovascular revascularization (76 patients) or supervised hospital-based exercise (75 patients).
MEASUREMENTS: Mean improvement of health-related quality-of-life and functional capacity over a 12-month period, cumulative 12-month costs, and incremental costs per quality-adjusted life year (QALY) were assessed from the societal perspective.
RESULTS: In the endovascular revascularization group, 73% (55 patients) had iliac disease vs 27% (20 patients) femoral disease. Stents were used in 46/71 iliac lesions (34 patients) and in 20/40 femoral lesions (16 patients). In the supervised hospital-based exercise group, 68% (51 patients) had iliac disease vs 32% (24 patients) with femoral disease. There was a non-significant difference in the adjusted 6- and 12-month EuroQol, rating scale, and SF36-physical functioning values between the treatment groups. The gain in total mean QALYs accumulated during 12 months, adjusted for baseline values, was not statistically different between the groups (mean difference revascularization versus exercise 0.01; 99% CI -0.05, 0.07; P = .73). The total mean cumulative costs per patient was significantly higher in the revascularization group (mean difference euro2318; 99% CI 2130 euros, 2506 euros; P < .001) and the incremental cost per QALY was 231 800 euro/QALY adjusted for the baseline variables. One-way sensitivity analysis demonstrated improved effectiveness after revascularization (mean difference 0.03; CI 0.02, 0.05; P < .001), making the incremental costs 75 208 euro/QALY.
CONCLUSION: In conclusion, there was no significant difference in effectiveness between endovascular revascularization compared to supervised hospital-based exercise during 12-months follow-up, any gains with endovascular revascularization found were non-significant, and endovascular revascularization costs more than the generally accepted threshold willingness-to-pay value, which favors exercise.
Sandra Spronk; Johanna L Bosch; Pieter T den Hoed; Hermanus F Veen; Peter M T Pattynama; M G Myriam Hunink
Related Documents :
20215969 - Exercise-based interventions and health-related quality of life in intermittent claudic...
11165969 - Effects of exercise rehabilitation on endothelial reactivity in older patients with per...
7552539 - Treatment of intermittent claudication: the impact on quality of life.
426319 - Comparison between reactive and exercise hyperemia in normal subjects and patients with...
16314239 - Systematic diagnostic approach to proximal-without-distal claudication in a vascular po...
562089 - Effect of chemical sympathectomy on muscle blood flow.
7225749 - The relationship between the number of capillaries in the skin of the venous ulcer-bear...
22375189 - Pre-participation cardiovascular screening of elderly wrestlers.
2300349 - Minimum extension and appropriate topographic position of tissue destruction for treatm...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial     Date:  2008-09-04
Journal Detail:
Title:  Journal of vascular surgery     Volume:  48     ISSN:  1097-6809     ISO Abbreviation:  J. Vasc. Surg.     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2009-01-02     Completed Date:  2009-01-22     Revised Date:  2012-10-03    
Medline Journal Info:
Nlm Unique ID:  8407742     Medline TA:  J Vasc Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1472-80     Citation Subset:  IM    
Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cost-Benefit Analysis
Exercise Therapy / economics*,  methods
Follow-Up Studies
Hospital Costs*
Intermittent Claudication / economics,  therapy*
Retrospective Studies
Time Factors
Treatment Outcome
Vascular Surgical Procedures / economics*,  methods

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Association between daily ambulatory activity patterns and exercise performance in patients with int...
Next Document:  Cognitive training improves clinically relevant outcomes during simulated endovascular procedures.